Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.

Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q36952629

about

Accelerated atherosclerosis in patients with SLE--mechanisms and management Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosus Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus Early vascular alterations in SLE and RA patients--a step towards understanding the associated cardiovascular risk.Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE Aggressive cardiac involvement in systemic lupus erythematosus: a case report and a comprehensive literature review.The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.Diverging trajectory patterns of systemic versus vascular inflammation over age in healthy Caucasians and African-Americans Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions Atherosclerosis in systemic lupus erythematosus.Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis.Alpha-chlorofatty Acid and coronary artery or aorta calcium scores in women with systemic lupus erythematosus. A pilot study.Semiquantified noncalcified coronary plaque in systemic lupus erythematosus.High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.Epicardial adipose tissue is increased in patients with systemic lupus erythematosus Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury.Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome.Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.Pathogenesis and treatment of atherosclerosis in lupus.Soluble E-selectin may predict progression of subclinical atherosclerosis, as measured by coronary artery calcium score and aorta calcium score, in women with systemic lupus erythematosus.Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus.

P2860

Q26820245-D32D0680-0DA5-4DE1-BA9F-78B2EA277B32 Q28071723-1C6FCFE2-5FDF-4ACF-BBD6-303195801097 Q33448450-489C37EA-CC3B-4BBA-858C-82306CF06F83 Q33570432-DA11A155-39C2-487A-B7D6-68D7D6BBB47D Q33604867-DA0416B0-0540-4B2E-8511-F947701D1F4A Q33686973-927B1075-4058-4256-B3DE-F9A73833A23E Q33799781-9E0CB6AD-D4B1-4FE3-AF0D-39649422BC6C Q34027495-FC51942A-E3C7-4294-B31C-4707677F7BCC Q34170097-028E5E00-568D-428B-9DC1-2CB9B2C916E1 Q34273836-00A6E88C-4C03-435F-A532-04547B2C93DC Q34288248-C8AD8A4D-8932-41F2-ADD9-A3BFBCDD9171 Q34409903-3F6B9D2B-C370-4A41-9C13-3EF32DCB9137 Q34486477-2C927357-FD54-4DE2-A6B4-6D273AC5687F Q34512778-4C69158B-6D24-488F-AA9F-559820DEE8FD Q34590968-C121AFD9-8C97-4575-BDF8-35FB12AF9C9D Q35169351-B742BD3A-35A4-4A1A-99C8-919E0769B76C Q35181453-51825D33-A2B6-4A92-8C9D-D0EF707D6F5A Q35214718-238209A6-DAE8-4760-B59D-7957C5C5BEE9 Q35525108-01B63824-DADD-4F9D-9DA0-CA689B80A93E Q35746107-A2D9BFC3-B596-45D1-8E8E-C479C20AD9C0 Q35921093-3E68DFA3-10F5-423D-A1F7-46A56AE0D6B1 Q36493881-1BB3D42D-628B-4EC7-B962-BEEDEECD5CE2 Q36709328-87700136-03D1-4F9D-B810-EA18AE6D0519 Q36714306-11109A80-7290-4692-A231-0409F2FFF2AF Q36785430-5E75EC94-4CC2-4993-B457-7412431374AE Q36934234-24803918-AE05-4E3F-A0A2-8928C1FAAD09 Q37436638-439244E2-45D5-4975-B995-5AF972C8A095 Q37625058-0C823064-88E4-48A8-B68C-BAB917B1CC12 Q37658803-5DE0394C-C1D5-4DF1-9693-3A15F47B277D Q37699812-7223BDFE-804C-4F7A-9297-E08455122FCD Q38230699-BEFD4653-101C-45D2-9651-10FEBDCC3655 Q46230857-F2AE4649-8479-48BA-B34D-20B2A8A73F7A Q52316454-A178B304-C7B6-431A-A9C2-E0D4A3635A0F

P2860

Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.

http://www.wikidata.org/entity/Q36952629

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Novel cardiovascular risk fact ...... systemic lupus erythematosus.

@en

type

label

Novel cardiovascular risk fact ...... systemic lupus erythematosus.

@en

prefLabel

Novel cardiovascular risk fact ...... systemic lupus erythematosus.

@en

P1433

Q36952629-84BD56A6-7478-49F6-B8D4-CE871505BAF5

P1476

Q36952629-9515F1A8-61B6-47DF-994F-AD0192762FF9

P2093

Q36952629-18000CB5-5A4A-44C3-ADC9-D2407BC75341

Q36952629-1C6FF19F-0F84-4F9A-9347-480611A3D027

Q36952629-321074D2-0C08-467C-B44B-CD690E9B4EAB

Q36952629-8BF822ED-AF8B-4102-9178-E503A2654D44

Q36952629-AF802CF0-290B-49C5-AF39-5322B75E6912

Q36952629-D6910894-4805-460B-BE01-138051CC250D

Q36952629-DF0B55FA-EDFF-4776-BD51-AAABDE3C73DF

P2860

Q36952629-02E98B29-83B0-46B0-B98E-AD6261E824CF

Q36952629-142BBD56-BA89-4971-B1AF-5A3700ECD2A2

Q36952629-1E474BCF-FC62-4FE5-9BAF-9215E5FCBFC9

Q36952629-242273F4-7CE1-4E42-A606-03DE0079A181

Q36952629-2AABB99A-984C-4AD4-865B-7B5A7B52D4A1

Q36952629-317D08ED-711D-4440-85EB-833992A7136D

Q36952629-36300386-3540-4C7E-B8F3-3584A377DEDF

Q36952629-3A404A86-C079-4EAF-8BC8-9FC123D78CEB

Q36952629-413649EC-EDF8-4DDF-BF9F-FDF802AB1073

Q36952629-414C630B-77E4-4EEC-809E-0503F40282C7

P304

Q36952629-3864786D-CAE4-4AB4-9F0C-ED3CBEDF13B5

P31

Q36952629-FD9F68CA-1E5C-42AF-9BD1-4329A5E50BD2

P407

Q36952629-B3873CAF-F028-4BB0-8E4A-4908F8D0AD24

P433

Q36952629-3DB193C4-FC17-46E3-91FB-29D1B0724D6A

P478

Q36952629-690AB671-BB7A-40D3-9080-D3EBBACE0120

P50

Q36952629-C7586503-1BB9-4323-8860-4081A55F2B3D

P577

Q36952629-C69DD72F-0FB5-4FD4-A1B4-B78C9FDD9A1D

P698

Q36952629-9063613E-69EE-48AC-AB4F-F6045F21B95E

P921

Q36952629-6AF3FFFA-E2AF-4DE3-8259-A55F1D8B25FE

Q36952629-C5E13FD6-51F2-4F38-80AE-7719B265AEF3

P932

Q36952629-DC604BE5-E29E-44AA-AD6C-7E241C97E82C

P1433

The Journal of Rheumatology

P1476

Novel cardiovascular risk fact ...... h systemic lupus erythematosus

@en

P2093

Annette Oeser

http://www.w3.org/2001/XMLSchema#string

Ayumi Shintani

http://www.w3.org/2001/XMLSchema#string

C Michael Stein

http://www.w3.org/2001/XMLSchema#string

Cecilia P Chung

http://www.w3.org/2001/XMLSchema#string

Joseph Solus

http://www.w3.org/2001/XMLSchema#string

Paolo Raggi

http://www.w3.org/2001/XMLSchema#string

Young Hee Rho

http://www.w3.org/2001/XMLSchema#string

P2860

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Inflammation, atherosclerosis, and coronary artery disease

The pathogenesis of atherosclerosis: a perspective for the 1990s

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Factors associated with coronary artery calcification in young female patients with SLE.

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Premature coronary-artery atherosclerosis in systemic lupus erythematosus.

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Association between myeloperoxidase levels and risk of coronary artery disease.

Inflammatory markers and the risk of coronary heart disease in men and women.

P304

1789-1794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Tebeb Gebretsadik

P577

2008-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18634156

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

atherosclerosis

P932

2574747

http://www.w3.org/2001/XMLSchema#string